| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1461145714000352 |
| P698 | PubMed publication ID | 24666527 |
| P50 | author | Tomas Furmark | Q42862961 |
| Fredrik Ahs | Q43255606 | ||
| Clas Linnman | Q48724267 | ||
| Massimo Bani | Q56944884 | ||
| Vanda Faria dos Santos | Q57894110 | ||
| Mats Fredrikson | Q66123110 | ||
| Emilio Merlo Pich | Q114419342 | ||
| Lieuwe Appel | Q116782167 | ||
| Paolo Bettica | Q116782171 | ||
| P2093 | author name string | Kurt Wahlstedt | |
| P2860 | cites work | Emotional processing in anterior cingulate and medial prefrontal cortex | Q24629806 |
| The cognitive control of emotion | Q28248075 | ||
| An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets | Q29614928 | ||
| A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder | Q30486593 | ||
| Sequence of information processing for emotions based on the anatomic dialogue between prefrontal cortex and amygdala. | Q30500209 | ||
| Ambiguous results in functional neuroimaging data analysis due to covariate correlation | Q30581764 | ||
| Neuroimaging in social anxiety disorder: a systematic review of the literature | Q33537558 | ||
| The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety | Q33887634 | ||
| Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy | Q33958852 | ||
| Social anxiety disorder. | Q34010741 | ||
| The placebo response in social phobia | Q34091943 | ||
| Overt versus covert treatment for pain, anxiety, and Parkinson's disease | Q34359487 | ||
| Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo | Q34436163 | ||
| Neurobiological mechanisms of the placebo effect. | Q34466524 | ||
| Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective | Q34493774 | ||
| Social phobia: overview of community surveys. | Q34592218 | ||
| Imaging the placebo response: a neurofunctional review | Q34780292 | ||
| A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. | Q34893258 | ||
| Modulating limbic-cortical circuits in depression: targets of antidepressant treatments | Q34968499 | ||
| Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder | Q35153746 | ||
| Anatomical insights into the interaction of emotion and cognition in the prefrontal cortex | Q35628147 | ||
| The adaptive threat bias in anxiety: amygdala-dorsomedial prefrontal cortex coupling and aversive amplification | Q35782856 | ||
| Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder | Q36174067 | ||
| Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia | Q36569739 | ||
| The extinction of conditioned fear: structural and molecular basis and therapeutic use. | Q36792585 | ||
| Amygdala-frontal connectivity during emotion regulation. | Q36935130 | ||
| A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. | Q37124836 | ||
| Amygdala and ventrolateral prefrontal cortex function during anticipated peer evaluation in pediatric social anxiety | Q37279150 | ||
| Functional connectivity of the human amygdala using resting state fMRI | Q37326109 | ||
| Changing fear: the neurocircuitry of emotion regulation | Q37587742 | ||
| Emotion, cognition, and mental state representation in amygdala and prefrontal cortex | Q37717658 | ||
| Social fearfulness in the human brain | Q37920189 | ||
| How expectations shape pain | Q37998736 | ||
| Placebo in emotional processing--induced expectations of anxiety relief activate a generalized modulatory network | Q39365805 | ||
| Placebo and opioid analgesia-- imaging a shared neuronal network | Q42162385 | ||
| What is the amygdala? | Q43987421 | ||
| A prefrontal non-opioid mechanism in placebo analgesia | Q44346158 | ||
| Coupling of theta activity and glucose metabolism in the human rostral anterior cingulate cortex: an EEG/PET study of normal and depressed subjects | Q44778317 | ||
| Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study | Q46459295 | ||
| The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests | Q46782308 | ||
| Functional coupling of the amygdala in depressed patients treated with antidepressant medication | Q46911638 | ||
| Prefrontal cortex modulates placebo analgesia | Q48421258 | ||
| Cingulate function in depression: a potential predictor of treatment response | Q48768060 | ||
| Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis | Q48965818 | ||
| Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder | Q50641255 | ||
| Selective imitation in domestic dogs. | Q51987770 | ||
| Evaluation of the clinical global impression scale among individuals with social anxiety disorder | Q73475997 | ||
| P433 | issue | 8 | |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | 1149-1157 | |
| P577 | publication date | 2014-03-26 | |
| P1433 | published in | The International Journal of Neuropsychopharmacology | Q7742309 |
| P1476 | title | Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder | |
| P478 | volume | 17 |
| Q31114020 | Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics |
| Q26781100 | Biological predictors of pharmacological therapy in anxiety disorders |
| Q42650671 | Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial |
| Q61443297 | Easier to Accelerate Than to Slow Down: Contributions of Developmental Neurobiology for the Understanding of Adolescent Social Anxiety |
| Q52150619 | Epigenetic variation in the serotonin transporter gene predicts resting state functional connectivity strength within the salience-network. |
| Q101454052 | Functional brain abnormalities associated with comorbid anxiety in autism spectrum disorder |
| Q27339489 | Neuroplasticity in response to cognitive behavior therapy for social anxiety disorder |
| Q47593921 | Pharmacotherapy for social anxiety disorder (SAnD). |
| Q38935410 | Placebo response in pain, fatigue, and performance: Possible implications for neuromuscular disorders. |
| Q26776255 | Rethinking psychopharmacotherapy: The role of treatment context and brain plasticity in antidepressant and antipsychotic interventions |
| Q30639770 | Serotonergic, brain volume and attentional correlates of trait anxiety in primates |
Search more.